Hollsteen
← Zoom

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2019: $6.0M · 10-Q 0001564590-19-022032 filed Jun 7, 2019Research and development · Q2 FY2019: $7.0M · 10-Q 0001585521-19-000020 filed Sep 13, 2019Research and development · Q3 FY2019: $9.0M · 10-Q 0001585521-19-000059 filed Dec 9, 2019Research and development · Q4 FY2019: $11.0M · derived · 10-K 0001585521-20-000095 filed Mar 20, 2020Research and development · Q1 FY2020: $14.0M · 10-Q 0001564590-19-022032 filed Jun 7, 2019Research and development · Q2 FY2020: $15.0M · 10-Q 0001585521-19-000020 filed Sep 13, 2019Research and development · Q3 FY2020: $18.0M · 10-Q 0001585521-19-000059 filed Dec 9, 2019Research and development · Q4 FY2020: $21.0M · derived · 10-K 0001585521-21-000048 filed Mar 18, 2021Research and development · Q1 FY2021: $26.0M · 10-Q 0001585521-20-000154 filed Jun 5, 2020Research and development · Q2 FY2021: $43.0M · 10-Q 0001585521-20-000238 filed Sep 3, 2020Research and development · Q3 FY2021: $43.0M · 10-Q 0001585521-20-000299 filed Dec 4, 2020Research and development · Q4 FY2021: $52.0M · derived · 10-K 0001585521-22-000037 filed Mar 7, 2022Research and development · Q1 FY2022: $65.0M · 10-Q 0001585521-21-000131 filed Jun 2, 2021Research and development · Q2 FY2022: $82.0M · 10-Q 0001585521-21-000235 filed Aug 31, 2021Research and development · Q3 FY2022: $99.0M · 10-Q 0001585521-21-000295 filed Nov 23, 2021Research and development · Q4 FY2022: $117M · derived · 10-K 0001585521-23-000035 filed Mar 3, 2023Research and development · Q1 FY2023: $144M · 10-Q 0001585521-22-000106 filed May 25, 2022Research and development · Q2 FY2023: $173M · 10-Q 0001585521-22-000180 filed Aug 24, 2022Research and development · Q3 FY2023: $196M · 10-Q 0001585521-22-000213 filed Nov 23, 2022Research and development · Q4 FY2023: $261M · derived · 10-K 0001585521-24-000030 filed Mar 4, 2024Research and development · Q1 FY2024: $209M · 10-Q 0001585521-23-000128 filed May 25, 2023Research and development · Q2 FY2024: $192M · 10-Q 0001585521-23-000194 filed Aug 23, 2023Research and development · Q3 FY2024: $197M · 10-Q 0001585521-23-000249 filed Nov 21, 2023Research and development · Q4 FY2024: $205M · derived · 10-K 0001585521-25-000042 filed Feb 28, 2025Research and development · Q1 FY2025: $206M · 10-Q 0001585521-24-000094 filed May 22, 2024Research and development · Q2 FY2025: $207M · 10-Q 0001585521-24-000181 filed Aug 23, 2024Research and development · Q3 FY2025: $223M · 10-Q 0001585521-24-000260 filed Nov 26, 2024Research and development · Q4 FY2025: $217M · derived · 10-K 0001585521-26-000030 filed Feb 27, 2026Research and development · Q1 FY2026: $205M · 10-Q 0001585521-25-000090 filed May 23, 2025Research and development · Q2 FY2026: $206M · 10-Q 0001585521-25-000141 filed Aug 22, 2025Research and development · Q3 FY2026: $210M · 10-Q 0001585521-25-000202 filed Nov 25, 2025Research and development · Q4 FY2026: $223M · derived · 10-K 0001585521-26-000030 filed Feb 27, 2026Research and development · Q1 FY2027: $228M · 10-Q 0001585521-26-000071 filed May 22, 2026Research and development · Q2 FY2027: $242M · 10-Q 0001585521-26-000121 filed Aug 26, 2026missing992426261aQ1 FY2016Q2 FY2027Q3 FY2022
$MResearch and development · Q3 FY2021: $43.0M · 10-Q 0001585521-20-000299 filed Dec 4, 2020Research and development · Q4 FY2021: $52.0M · derived · 10-K 0001585521-22-000037 filed Mar 7, 2022Research and development · Q1 FY2022: $65.0M · 10-Q 0001585521-21-000131 filed Jun 2, 2021Research and development · Q2 FY2022: $82.0M · 10-Q 0001585521-21-000235 filed Aug 31, 2021Research and development · Q3 FY2022: $99.0M · 10-Q 0001585521-21-000295 filed Nov 23, 2021Research and development · Q4 FY2022: $117M · derived · 10-K 0001585521-23-000035 filed Mar 3, 2023Research and development · Q1 FY2023: $144M · 10-Q 0001585521-22-000106 filed May 25, 2022Research and development · Q2 FY2023: $173M · 10-Q 0001585521-22-000180 filed Aug 24, 20229917343Q3 FY2021Q2 FY2023Q3 FY2022
Q3 FY2022
99$M
All values (34)
PeriodValue ($M)Status
Q2 FY2027242reported
Q1 FY2027228reported
Q4 FY2026223derived
Q3 FY2026210reported
Q2 FY2026206reported
Q1 FY2026205reported
Q4 FY2025217derived
Q3 FY2025223reported
Q2 FY2025207reported
Q1 FY2025206reported
Q4 FY2024205derived
Q3 FY2024197reported
Q2 FY2024192reported
Q1 FY2024209reported
Q4 FY2023261derived
Q3 FY2023196reported
Q2 FY2023173reported
Q1 FY2023144reported
Q4 FY2022117derived
Q3 FY202299reported
Q2 FY202282reported
Q1 FY202265reported
Q4 FY202152derived
Q3 FY202143reported
Q2 FY202143reported
Q1 FY202126reported
Q4 FY202021derived
Q3 FY202018reported
Q2 FY202015reported
Q1 FY202014reported
Q4 FY201911derived
Q3 FY20199reported
Q2 FY20197reported
Q1 FY20196reported

12 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for Zoom

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$99.0M
Period
Q3 FY2022, ended Oct 31, 2021 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Nov 23, 2021 · 0001585521-21-000295
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$99.0MNov 23, 202110-Q 0001585521-21-000295reported · confidence 1. · current